Moderna Applies for Emergency F.D.A. Approval for Its Coronavirus Vaccine
The first shots could be given as early as Dec. 21, if authorization is granted.

https://www.nytimes.com/2020/11/30/health/covid-vaccine-moderna.html

-----------------------

'Absolutely remarkable' : No one who got Moderna's vaccine in trial developed severe COVID-19

https://www.sciencemag.org/news/2020/11/absolutely-remarkable-no-one-who-got-modernas-vaccine-trial-developed-severe-covid-19

Moderna Applies for Emergency F.D.A. Approval for Its Coronavirus Vaccine
The first shots could be given as early as Dec. 21, if authorization is granted.

https://www.nytimes.com/2020/11/30/health/covid-vaccine-moderna.html

-----------------------

'Absolutely remarkable' : No one who got Moderna's vaccine in trial developed severe COVID-19

https://www.sciencemag.org/news/2020/11/absolutely-remarkable-no-one-who-got-modernas-vaccine-trial-developed-severe-covid-19

Pharmaniaga sets up task force as it gears up to distribute Covid-19 vaccine

https://www.theedgemarkets.com/article/pharmaniaga-sets-task-force-it-gears-distribute-covid19-vaccine

Moderna Applies for Emergency F.D.A. Approval for Its Coronavirus Vaccine
The first shots could be given as early as Dec. 21, if authorization is granted.

https://www.nytimes.com/2020/11/30/health/covid-vaccine-moderna.html

-----------------------

'Absolutely remarkable' : No one who got Moderna's vaccine in trial developed severe COVID-19

https://www.sciencemag.org/news/2020/11/absolutely-remarkable-no-one-who-got-modernas-vaccine-trial-developed-severe-covid-19

Moderna Applies for Emergency F.D.A. Approval for Its Coronavirus Vaccine
The first shots could be given as early as Dec. 21, if authorization is granted.

https://www.nytimes.com/2020/11/30/health/covid-vaccine-moderna.html

-----------------------

'Absolutely remarkable' : No one who got Moderna's vaccine in trial developed severe COVID-19

https://www.sciencemag.org/news/2020/11/absolutely-remarkable-no-one-who-got-modernas-vaccine-trial-developed-severe-covid-19

Yes I am investing long term because I believe in the bright future prospect of Kanger.

This friendship is really bad bad bad for trapping his followers with his vaccine lies lol pity his followers who blindly believed in his vaccine fantasies. Now they have to pay for the consequences. Sad.

Be careful of friendship. Keep on making up stories regarding titijaya vaccine deals . He is trying to attack other counters to distract his followers from his vaccine lies lol

@Noobie123 Me too. If drop i will top up.

@BigBladd Exactly. Nowhere in the titijaya agreement is it mentioned vaccines lol

Their high tech bamboo plant will only be operating in 4th quarter

Be careful of this friendship. The biggest conman in this forum.

@friendship enough with your tititjaya vaccine deal fantasies lol they will only be distributing medical equipments. Don’t be so delusional. Continue hoping until 2050 also there will be no vaccine deal for titijaya kekeke ...

@scenery totally agree with you...

@friendhsip I only share facts from published news articles unlike you spreading lies , grandfather stories and baseless fairytales in your titijaya forum. Pity all your followers blindly listening to your lies lolol

Becareful of friendship. No.1 conman in this forum.

@friendship continue spreading lies regarding your titijaya vaccine deal . God will punish you one day for conning your followers

@scenery no point trying to reason with the people in this forum. They are brain dead zombies who just blindly follow friendship their cult leader lolol

Remember it is a sin to lie and both of you are lying through your teeth everyday that titijaya has an agreement to distribute sinopharm vaccines lol Jokers

@titijayamedical stop conning your followers that titijaya will be distributing sinopharm vaccines lol what a joke both you an friendship

@friendship As you have noticed , kanger is very resilient. Even with bad news, price also will not move much. Maybe your titijaya is work 0.05 and below for all the lies you are spreading regarding titijaya lol

@Friendship You are conning your followers everyday that Titijaya will be distributing Sinopharm vaccines Lol what a joke

Remember that the fate of China is hinging on these vaccines. The government is doing all that they can to ensure that the vaccines quality, safety and efficacy meet international standards so that they can redeem themselves via their vaccine diplomacy.

@Fong Kh Most probably not mentioned because vaccine is subjected to approval by authorities. If rejected, then the agreement is off. However, in my opinion, chances of rejection by the authorities is low as Sinopharm has been working very closely with World Health Organization in the development and clinical trials of the vaccine. Hence, the vaccine is almost guaranteed to meet international standards.

The Group has identified the following main strategies to continue to grow its businesses:-

(a) Expansion into new bamboo concession and processing plant in Jingzhou, the PRC
which is currently under construction and targeted to be completed and to start
operations in the third quarter of FYE 2020, in order to better manage raw material
costs, as the new plant is surrounded by an estimated 18,200 metric tonnes standing
stock of ready-to-harvest raw bamboo (translating to an estimated 435,000 square
metres of bamboo flooring). This will be a steady source of raw material supply and
key factor in the re-upscaling of our own bamboo products segment. The expansion in
Jingzhou will allow the Group to focus not only on manufacturing of bamboo products
but also processing of bamboo related foodstuff and bamboo eco-tourism in the near
future;

(b) Expansion of the Group’s flooring products with the launching of new series of
bamboo flooring products;

(c) Enhancing the Group’s flooring products to focus more on ‘green’ strand woven
products;

(d) Expansion of the Group’s product portfolio to include bamboo furniture marketed
under the ‘KAR-ACE’ brand;

(e) Expansion into wood flooring products by promoting Classen’s products in the PRC
through the collaboration with Classen GmbH as the Group is the exclusive distributor
for Classen’s products in the PRC. The COVID-19 pandemic and related lockdowns
has had a significant impact on general business activity and there is always a risk of
second and additional waves occurring in the future. As a result, the Group is
currently in discussions with Classen on reducing the scope of the exclusivity from
China-wide to perhaps focus on Guangdong province or the southern region where
our main and sales offices are. The reason for this is to avoid incurring potential
penalties in the future for not meeting minimum sales targets should the pandemic
turn into a longer term problem.

(f) Expansion of the Group’s presence by increasing the number of appointed dealers in
its sales network and number of sales and marketing channels, for both its own and
third party products;

(g) Identifying candidates to be the Group’s master agents/distributors in countries such
as Malaysia, Australia and New Zealand;

(h) Intensifying efforts in the adoption and building out of a comprehensive omni-channel
marketing strategy which is designed to cover all points of contact with existing and
potential new customers. The Group is also cooperating closely with its dealers in
implementing effective Online-to-Offline marketing and delivery channels. The online
platforms include JD.com, Alibaba’s Taobao and various mini-programs offered by
social media networks like WeChat; and

(i) Diversification of the Group’s principal activities to include property leasing business
which will provide the Group with additional income and cash flows.During the current
financial quarter, the Group has fully leased out its newly completed commercial
properties with a total net lettable area of 683,777 sq ft, comprising a 19-storey hotel
and a 6-storey building specifically outfitted as a one-stop “Auto-City”. The initial
rental income is approximately RM11.1 million per annum, with scheduled rent
increases (for details, refer to Bursa Malaysia announcement dated 9 March, 2020).

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3109880

QR bad is to be expected. Now that the new high-tech bamboo processing plant is starting operation soon and China economy is back on track plus the various diversifications, including healthcare, next year will be a better year for Kanger.

@jasonred79 You don't have to put on an act here and pretend you are so "concerned" about others. We know our risks and we are willing to take that risk. You so kiasi then sayonara to you

@jasonred79 At the end of the day your money you decide. My money i decide. Everyone has got a different risk appetite. You dont expect everyone to follow your style. You have to respect that.

@jasonred79 Just keep the info to yourself. I am not interested to know. No need to be so pretentious here lol

@jasonred79 If you already lost faith in Kanger. Why come here and waste your time babbling non stop ? lolol

@jasonred79 Ya i am not interested in your story. Sayonara. You already sold your shares why make so much noise here lolol

@purple_rain Apparently the budget debate regarding the allocation for each ministry will go on for 2 weeks...

Anyway today gloves went up so vaccines will naturally drop...

@purple_rain Still many more ministries to go. Budget debate still ongoing.

@jasonred79 Please do not come into this forum and make up some story about some god knows who lawyer who doesnt exist. We are not interested to read your fairytales here lol

Unlikely 195. Today will close at 185.

Today i predict Kanger will close at 0.185...

@Noobie123 I will need to do some digging...

@18KHarmoni Sebab aiyooo selalu datang kacau sini.....

@purple_rain Generex is still in pre-clinical stage

Any good news?

Pity those stuck at 1.40...

@scenery These people here are delusional. Keep on dreaming about vaccine deals...smh

Its soo obvious Cansino vaccine is out of the question in the vaccine agreement between Malaysia and China lol Stop dreaming....

@drteh84 Face it. Sinopharm vaccine is way ahead of Cansino vaccine in phase 3 and higher chance of being the one supplied to Malaysia based on the vaccine agreement with China. Sinopharm is state owned whereas Cansino is private. Safety profile of inactivated vaccines is proven. Safety profile of Adenovirus vector vaccine is questionable.

With more and more vaccine news coming out. Dowside risk is low. Higher chance of upside.

Better than Solution from 1.4 to 1.17 now 1.3. The movement is too drastic.

I still remember this Paktua from 3 years ago. I stopped trading for 3 years and only restarted in September this year. tut tut

If everyday can close 1 bid higher i am happy already.

By the time Cansino Vaccine is approved, 70% of Malaysians would have already been vaccinated kekeke